Please assess the completion status of the following clinical trial:

Trial Title: Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Participant is willing and able to give informed consent for participation in the trial~* Male or Female, aged 18 years or above~* Histologically verified NSCLC~* Patients with any stage NSCLC where radical radiotherapy (with either conventionally fractionated treatment or with stereotactic body radiotherapy (SABR)) or chemoradiotherapy (concurrent or sequential schedule) is considered appropriate~* WHO performance status 0-2~* Able (in the Investigators opinion) and willing to comply with all study requirements~Exclusion Criteria:~* Inability to give written informed consent~* Female participant who is pregnant, lactating or planning pregnancy during the course of the trial~* Previous radiotherapy to the chest~* The presence of another condition where the disease itself or treatment may interfere with the study endpoints~* Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule~* Inability to lie flat for imaging~* Contraindications to MRI examination including indwelling pacemaker, non-MRI compatible metallic implant, severe claustrophobia, intra-ocular foreign body~* Contraindications for gadolinium enhanced lung MRI scan - known hypersensitivity/allergy to the injection of MultiHance (contains gadobenate dimeglumine and small quantities of benzyl alcohol) that is given as part of this scanning or an adverse reaction to an injection given during previous MRI scanning, severe renal impairment~* Contraindications for ventilation/perfusion nuclear medicine scanning - known hypersensitivity to albumin or preference to avoid blood donation product~* Epilepsy requiring on-going medical treatment, or a seizure within the past year

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 129 Xenon MR Imaging (Type: EXPERIMENTAL): Xenon gas is inhaled immediately before acquisition of an MR image to enable the lung structure to be seen.

Based on this trial design, predict the completion outcome and termination type (if applicable).